Source: CURATED ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs60086424
rs60086424
LOC730100
T 0.700 GeneticVariation GWASCAT Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008. 30450575

2019
dbSNP: rs60218192
rs60218192
HS3ST4
A 0.700 GeneticVariation GWASCAT Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008. 30450575

2019
dbSNP: rs73062673
rs73062673
CNOT3 ; LOC102724273
C 0.700 GeneticVariation GWASCAT Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008. 30450575

2019
dbSNP: rs73195662
rs73195662
CDHR3
G 0.700 GeneticVariation GWASCAT Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008. 30450575

2019
dbSNP: rs10949482
rs10949482
NHLRC1
T 0.700 GeneticVariation GWASCAT NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia. 30201983

2018
dbSNP: rs2069426
rs2069426
CDKN2B ; CDKN2B-AS1
A 0.700 GeneticVariation GWASCAT GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21. 29348612

2018
dbSNP: rs2290400
rs2290400
GSDMB
T 0.700 GeneticVariation GWASCAT GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21. 29348612

2018
dbSNP: rs2390536
rs2390536
SP4
A 0.700 GeneticVariation GWASCAT GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21. 29348612

2018
dbSNP: rs2622849
rs2622849
COL11A1
T 0.700 GeneticVariation GWASCAT Bone mineral density in children with acute lymphoblastic leukemia. 29266176

2018
dbSNP: rs4617118
rs4617118
CCDC26
G 0.700 GeneticVariation GWASCAT GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21. 29348612

2018
dbSNP: rs4748813
rs4748813
PIP4K2A
T 0.700 GeneticVariation GWASCAT GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21. 29348612

2018
dbSNP: rs79050301
rs79050301
TPMT
C 0.700 GeneticVariation GWASCAT NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia. 30201983

2018
dbSNP: rs1142345
rs1142345
TPMT
0.700 GeneticVariation GWASCAT Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait. 27564568

2017
dbSNP: rs12748152
rs12748152 		C 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs144104656
rs144104656 		G 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs147481775
rs147481775
DEPDC5
A 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs149940960
rs149940960
GREB1
T 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs34531324
rs34531324
LINC01411
T 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs41307935
rs41307935
ZDHHC18
C 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs4896310
rs4896310
LOC105378021
A 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs637868
rs637868
PHGDH
C 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs6550253
rs6550253
LINC01811
A 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs6684897
rs6684897 		G 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs72772090
rs72772090
CAST
G 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017
dbSNP: rs738408
rs738408
PNPLA3
T 0.700 GeneticVariation GWASCAT Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy. 28090653

2017